Encision Inc Revenue Growth Rates (ECIA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Encision Inc   (ECIA)
 

ECIA's Revenue Growth by Quarter and Year

Encision Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ECIA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter March -
3rd Quarter December -
2nd Quarter September 1.53
1st Quarter June 1.60
FY 3.13

ECIAs Annual Revenue
Encision Inc 's Revenue in the fiscal year 2025 $ 6.56 millions
Encision Inc 's Revenue in the fiscal year 2024 $ 6.59 millions
Encision Inc 's Revenue in the fiscal year 2023 $ 7.35 millions
Encision Inc 's Revenue in the fiscal year 2022 $ 7.67 millions
Encision Inc 's Revenue in the fiscal year 2021 $ 7.54 millions




ECIA Revenue second quarter 2026 Y/Y Growth Comment
Encision Inc reported fall in Revenue in the second quarter 2026 by -13.18% to $ 1.53 millions, from the same quarter in 2025.
The decline in the second quarter 2026 Encision Inc 's Revenue compares unfavorably to the Company's average Revenue decrease of -4.46%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue growth. While Encision Inc ' s Revenue decrease of -13.18% ranks overall at the positon no. 2098 in the second quarter 2026.


ECIA Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter March - 3.95 % -16.02 % 13.12 %
3rd Quarter December - 0.63 % -5.95 % -13.4 %
2nd Quarter September -13.18 % -3.83 % 7.65 % -19.43 %
1st Quarter June -1.84 % -1.21 % -23.26 % 6.97 %
FY   - -0.3 % -10.35 % -

Financial Statements
Encision Inc 's second quarter 2026 Revenue $ 1.53 millions ECIA's Income Statement
Encision Inc 's second quarter 2025 Revenue $ 1.76 millions Quarterly ECIA's Income Statement


ECIA Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter March - -0.63 % -3.8 % 7.74 %
3rd Quarter December - -9.66 % -13.66 % -1.18 %
2nd Quarter September -4.5 % 7.98 % 10.91 % -20.93 %
1st Quarter June 1.27 % 7.24 % -8.84 % 34.37 %
FY (Year on Year)   - -0.3 % -10.35 % -


Back to ECIA Growth rate Comparisons >> Back to ECIA Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #312
Overall #2098

Revenue Y/Y Growth Statistics
High Average Low
19.67 % -4.46 % -14.86 %
(Sep 30 2021)   (Jun 30 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #312
Overall #2098
Revenue Y/Y Growth Statistics
High Average Low
19.67 % -4.46 % -14.86 %
(Sep 30 2021)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Encision Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
39.54 % -0.66 % -24.22 %
(Sep 30 2020)  


ECIA's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Encision Inc disclosed fall in Revenue from the first quarter by -4.5% to $ 1.53 millions, from $ 1.60 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue quarter on quarter growth. While Encision Inc 's Revenue growth quarter on quarter, overall rank is 2587.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #377
Overall #2587
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #377
Overall #2587
Revenue Q/Q Growth Statistics
High Average Low
39.54 % -0.66 % -24.22 %
(Sep 30 2020)  


ECIA's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Encision Inc disclosed fall in Revenue from the first quarter by -4.5% to $ 1.53 millions, from $ 1.60 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue quarter on quarter growth. While Encision Inc 's Revenue growth quarter on quarter, overall rank is 2587.


Encision Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)
Cumulative Revenue 12 Months Ending $ 6.30 $ 6.53 $ 6.56 $ 6.50 $ 6.49
Y / Y Revenue Growth (TTM) -2.97 % -0.55 % -0.46 % -5.4 % -6.85 %
Year on Year Revenue Growth Overall Ranking # 2728 # 2375 # 2849 # 1230 # 2185
Seqeuential Revenue Change (TTM) -3.48 % -0.43 % 0.91 % 0.06 % -1.08 %
Seq. Revenue Growth (TTM) Overall Ranking # 2347 # 2083 # 2488 # 1095 # 1569


Cumulative Revenue growth Comment
Encision Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -2.97% year on year, at Sep 30 2025 compare to the -0.55% decrease at Jun 30 2025. If the Encision Inc 's fiscal year would end at Sep 30 2025, annual Revenue would be $6 millions.

In the Healthcare sector 372 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2375 to 2728.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 124
Healthcare Sector # 373
Overall # 2728

Revenue TTM Y/Y Growth Statistics
High Average Low
19.67 %
 -4.46 %
-14.86 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 124
Sector # 340
S&P 500 # 2347
Cumulative Revenue growth Comment
Encision Inc 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -2.97% year on year, at Sep 30 2025 compare to the -0.55% decrease at Jun 30 2025. If the Encision Inc 's fiscal year would end at Sep 30 2025, annual Revenue would be $6 millions.

In the Healthcare sector 372 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2375 to 2728.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 124
Healthcare Sector # 373
Overall # 2728

Revenue TTM Y/Y Growth Statistics
High Average Low
19.67 %
-4.46 %
-14.86 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 124
Sector # 340
S&P 500 # 2347




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ECIA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2025
Community Health Systems Inc -0.10%$ -0.097 millions
Bioventus Inc -0.23%$ -0.232 millions
Bruker Corporation-0.39%$ -0.394 millions
Charles River Laboratories International inc -0.49%$ -0.486 millions
Protalix Biotherapeutics inc -0.60%$ -0.601 millions
Jaguar Health Inc -0.80%$ -0.804 millions
Bio techne Corp-1.01%$ -1.005 millions
Agilon Health Inc -1.08%$ -1.076 millions
Picard Medical Inc -1.25%$ -1.249 millions
Nexgel Inc -1.71%$ -1.709 millions
Capsovision Inc -1.75%$ -1.753 millions
Utah Medical Products Inc-2.02%$ -2.020 millions
10x Genomics Inc -2.04%$ -2.038 millions
Hyperfine Inc -2.06%$ -2.063 millions
Teladoc Health Inc -2.20%$ -2.197 millions
Lineage Cell Therapeutics Inc -2.59%$ -2.593 millions
Pacific Biosciences Of California Inc -2.83%$ -2.828 millions
Pluri Inc -3.07%$ -3.067 millions
Castle Biosciences Inc -3.19%$ -3.193 millions
Bionexus Gene Lab Corp -3.29%$ -3.291 millions
Nrc Health-3.38%$ -3.381 millions
Prestige Consumer Healthcare Inc -3.46%$ -3.459 millions
Sight Sciences Inc -3.57%$ -3.567 millions
Pediatrix Medical Group Inc -3.58%$ -3.577 millions
Quidelortho Corp-3.74%$ -3.741 millions
Escalon Medical Corp -3.81%$ -3.813 millions
Myriad Genetics Inc -3.98%$ -3.985 millions
Plus Therapeutics Inc -4.05%$ -4.052 millions
Perrigo Company Plc-4.07%$ -4.074 millions
P3 Health Partners Inc -4.66%$ -4.659 millions


About Encision Inc Revenue Growth Rates (ECIA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Encision Inc (CIK 930775).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001079973-25-001709
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Encision Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.